HLF and hTERT cooperatively enable partial immortalization of human hematopoietic stem and progenitor cells
Open Access
- 12 January 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 13, 1731355
Abstract
Hematopoietic stem and progenitor cells (HSPCs), residing at the apex of the hematopoietic hierarchy, are critical for the generation of all blood and immune cell lineages. This unique capacity makes HSPCs indispensable for advancing cell and gene therapies aimed at correcting defects across hematopoietic lineages. However, current gene therapy development is constrained by the requirement for fresh primary HSPCs, hindering the breadth of preclinical validation. While several hematopoietic lineages have been immortalized to facilitate research, the stable immortalization of human HSPCs remains unreported. Here, we demonstrate that combinatorial overexpression of HLF, a key regulator of stem cell maintenance, and hTERT, a telomere maintenance factor in primitive human HSCs, supported by BaEV-mediated transduction and optimized culture conditions, yields partial immortalization of HSPCs. These genetically modified cells sustained for up to 70 days and exhibited limited differentiation towards erythroid, megakaryocytic, and macrophage lineages. Our model establishes a protocol for generating primary cell like context for testing gene therapy strategies, enabling functional assessment in both undifferentiated HSPCs and their lineage-committed progeny.Keywords
This publication has 16 references indexed in Scilit:
- Long-term engrafting multilineage hematopoietic cells differentiated from human induced pluripotent stem cellsNature Biotechnology, 2024
- Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cellsMolecular Therapy, 2023
- Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathiesMolecular Therapy Nucleic Acids, 2023
- Chemically defined cytokine-free expansion of human haematopoietic stem cellsNature, 2023
- Mapping human haematopoietic stem cells from haemogenic endothelium to birthNature, 2022
- Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating StrategiesStem Cells Translational Medicine, 2022
- Preferential Expansion of Human CD34 + CD133 + CD90 + Hematopoietic Stem Cells Enhances Gene-Modified Cell Frequency for Gene TherapyHuman Gene Therapy, 2022
- Hematopoietic stem cells retain functional potential and molecular identity in hibernation culturesStem Cell Reports, 2021
- MLLT3 governs human haematopoietic stem-cell self-renewal and engraftmentNature, 2019
- Hepatic Leukemia Factor Maintains Quiescence of Hematopoietic Stem Cells and Protects the Stem Cell Pool during RegenerationCell Reports, 2017